Bausch + Lomb Investor Relations Material
Latest events
Q3 2024
Bausch + Lomb
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Bausch + Lomb Corporation
Access all reports
Bausch + Lomb is a leading global company that specializes in eye care products, ophthalmic surgical devices and lasers, contact lens products and lens care products. Its three major segments include Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals and Surgical. The Vision Care/Consumer Health Care segment offers products for the diagnosis, treatment and management of eye disease; including pharmaceuticals, medical equipment (including diagnostic imaging systems), surgical devices and lasers. The Ophthalmic Pharmaceuticals segment develops and markets therapeutics designed to treat diseases of the eye, conditions affecting the optic nerve and peripheral vision. The Surgical segment designs and manufactures instruments used by surgeons during cataract surgery procedures.
Key slides for Bausch + Lomb Corporation
Q3 2024
Bausch + Lomb Corporation
Q2 2024
Bausch + Lomb Corporation
Latest articles
Rocket Lab: Breaking Ground in Space
Rocket Lab has been one of the pioneers in the commercial aerospace industry, with numerous satellite launches and space system applications.
9 Dec 2024
Anthony Noto: The Multifaceted CEO of SoFi
Anthony Noto built a successful and diverse career across multiple industries before becoming CEO of the fintech company SoFi.
9 Dec 2024
Master of Tickets: Breaking Down Live Nation Entertainment
Since merging in 2010, Ticketmaster and Live Nation have built an expansive ecosystem that dominates global live entertainment.
6 Dec 2024
Ticker symbol
BLCO
Country
🇨🇦 Canada